Decrease of IFN-γ by propranolol in our findings is consistent with Seyedi et al. study17 in which propranolol significantly diminished IFN-γ secretion in tumor-infiltrating lymphocytes and peripheral blood mononuclear cells (PBMCs) of colorectal cancer patients. This evidence concerns the gene IFNG and colorectal cancer.